3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
86
Lung Neoplasms
64
Carcinoma, Non-Small-Cell Lung
50
Neoplasm Metastasis
48
Breast Neoplasms
48
Glioma
41
Glioblastoma
38
Pancreatic Neoplasms
35
Multiple Myeloma
35
Brain Neoplasms
34
Carcinoma, Renal Cell
33
Lymphoma, Large B-Cell, Diffuse
29
Melanoma
28
Urinary Bladder Neoplasms
27
Colorectal Neoplasms
27
Squamous Cell Carcinoma of Head and Neck
25
Ovarian Neoplasms
24
Triple Negative Breast Neoplasms
21
Oropharyngeal Neoplasms
21
Carcinoma, Hepatocellular
21
Lymphoma
20
Mouth Neoplasms
18
Lymphoma, Follicular
18
Sarcoma
17
Fallopian Tube Neoplasms
16
Carcinoma, Transitional Cell
16
Carcinoma
16
Laryngeal Neoplasms
15
Astrocytoma
15
Lymphoma, Mantle-Cell
14
Interventions
Specimen Handling
8
Tamoxifen
6
Standard of Care
4
Practice Guidelines as Topic
4
Radiotherapy
3
Methods
3
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Radiation
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
ruxolitinib
1
pembrolizumab
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Telemedicine
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Starch
1
Reverse Transcriptase Polymerase Chain Reaction
1
Ranitidine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
Magnetic Resonance Spectroscopy
×
1 year
×
Clear all
NCT06671912
2026-06-02
LoTam
Alliance for Clinical Trials in Oncology
Phase 3
Suspended
1,156 enrolled